IBD is a financial research app providing stock analysis, curated lists, and market news to individual investors on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
#45
▼3Finance · grossing
Sentiment
4.6
20k reviews
Nemesis
Seeking Alpha: News & Analysis
The App DNA
What makes this app unique?
Users hire IBD to filter market noise into actionable momentum-trading signals, reducing the time required to identify high-growth stock candidates.
For Individual DIY investors and traders seeking professional-grade stock research.
What does it look like?
Key features
Proprietary stock analysis metrics
Curated lists like IBD 50
Synced watchlists across devices
How much does it cost?
Subscription model anchored at $34.99/month, utilizing a one-month free trial to drive conversion.
Velocity
Maintenance developmentperformanceopaqueShow more...
The app maintains a release cadence of approximately 0.25 releases per week, placing it in the maintenance tier. Development activity is currently limited to minor bug fixes and performance optimizations, with no evidence of new features or live-ops content. The publisher consistently uses opaque release notes, suggesting that updates are focused on stability rather than user-facing changes. This stable, low-frequency pattern has remained consistent over the analyzed period.
Who built it?
Investor’s Business Daily
4 apps tracked · Finance
User Sentiment
What do users think recently?
Fresh user feedback skews mixed. Users appreciate actionable stock market data and technical analysis tools provide significant value for active traders, but report persistent technical failures including chart loading errors and missing data lists disrupt the user experience.
How are ratings & reviews evolving?
What users say, by theme
- Actionable stock market data and technical analysis tools provide significant value for active traders
- Persistent technical failures including chart loading errors and missing data lists disrupt the user experience
64 of 132 recent reviews analyzed · high confidence · Mixed overall
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Investor's Business Daily
How's the Finance market?
IBD holds a #71 Grossing position in the US Finance category, but the gap between its free-tier discovery and paid-tier conversion remains a primary friction point.
Read the market outlookThe rivals identified
By Seeking Alpha Ltd.
Seeking Alpha dominates the investment research niche by combining professional-grade analysis with a massive, highly engaged community of contributors.
- Crowdsourced investment thesis platform provides deeper qualitative analysis than IBD's proprietary editorial content.
- Extensive earnings call transcripts and audio summaries offer a comprehensive research layer IBD lacks.
- Aggregated sentiment data from thousands of contributors creates a powerful network effect for retail investors.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Investor's Business Daily
Where is it heading?
The financial research market is consolidating around platforms that offer both deep data and community-driven insights. IBD remains advantaged by its proprietary editorial signal, but the lack of technical polish leaves it exposed to competitors with faster release cadences.
- Persistent chart-loading failures in the latest release erode user trust, which directly increases churn among high-value subscribers.
- Proprietary Smart Select Ratings continue to drive high-value engagement, maintaining the app's relevance for momentum-focused DIY investors.
The SWOT
- Proprietary Smart Select Ratings function as a high-value differentiator
- Cross-device sync creates high switching costs
- Untapped education partnerships for B2B distribution
- Lack of tablet-optimized layouts
Next best moves
The counter-intuitive read
The high subscription price is not a bug…
Read the full takeFeature gaps
Real-time earnings call transcripts (available in Seeking Alpha but absent here)
Since the last report: The app has entered a maintenance phase characterized by declining sentiment scores and persistent technical bugs that are eroding user trust.
Bottom line
IBD retains power users through proprietary stock ratings, but technical instability and aggressive monetization threaten long-term retention, so the PM must prioritize core stability over new feature growth.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated